Pfizer’s COVID-19 vaccine clears key hurdle
The FDA's Vaccines and Related Biological Products Advisory Committee's recommendation to the agency for emergency use authorization of Pfizer and BioNTech's COVID-19 vaccine will likely lead to approval of the vaccine in a matter of days.